Status:

UNKNOWN

Understanding Patient's Knowledge and Use of Acetaminophen

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Liver Failure

Eligibility:

All Genders

13+ years

Brief Summary

Introduction to Study Objectives: In a joint collaboration of the Centers for Education and Research on Therapeutics (CERTS) at The University of Pennsylvania and the M.D. Anderson Cancer Center, thi...

Detailed Description

Individual Interviews: If you agree to take part in this study, you will take part in individual interview session. The interviews will be conducted by phone and audiotaped (recorded) and transcribed...

Eligibility Criteria

Inclusion

  • English or Spanish language proficiency.
  • Residence in Metropolitan Houston, Texas.
  • Adequate cognition as determined by the research staff through the use of questions related to orientation about person, time and place.
  • Adolescents who are 13 to 20 years of age who have ever heard of over-the-counter medication (We will recruit 20 adolescents through their parents, who will be required to give consent before the study staff contacts the child);or parents of children (either a mother or a father, but only one parent per family) under 8 years of age who have ever given their children an over- the-counter medication; or adults (21 years of age or older) who have used over-the-counter medication in the past 2 years.
  • Primary care physicians will be Family Practitioners or General Internist, with an active Texas license, who devote at least 50% of their time to clinical practice.
  • Pharmacists will hold a PharmD degree and licensure in the state of Texas and work at least half-time in a community pharmacy setting.

Exclusion

  • Participants who do not give informed consent.
  • A parent whose spouse/partner is/has already participated in the focus group.
  • Pharmacists actively enrolled in a training program.
  • Physicians who are participating in a fellowship or residency training program.
  • Children who may be depressed or at risk of suicide or managing that risk.

Key Trial Info

Start Date :

December 19 2008

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2020

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT00823758

Start Date

December 19 2008

End Date

December 1 2020

Last Update

January 27 2020

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

The Children's Hospital of Philadelphia, University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

2

Baylor College of Medicine

Houston, Texas, United States, 77030

3

Harris County Hospital District Outpatient Clinics

Houston, Texas, United States, 77030

4

Kelsey Seybold

Houston, Texas, United States, 77030